Lite Strategy, Inc. (LITS)
NASDAQ: LITS · Real-Time Price · USD
1.670
-0.080 (-4.57%)
At close: Dec 5, 2025, 4:00 PM EST
1.736
+0.066 (3.93%)
After-hours: Dec 5, 2025, 6:56 PM EST
Lite Strategy Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
61.43M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
LITS News
- 3 months ago - MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS' - Business Wire
- 4 months ago - MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising - Business Wire
- 4 months ago - BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode - TheNewswire
- 4 months ago - MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
- 5 months ago - Why Is MEI Pharma Stock Soaring On Friday? - Benzinga
- 5 months ago - MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
- 7 months ago - MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position - Business Wire
- 10 months ago - MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position - Business Wire